Latest Partnerships News

Noxopharm’s Sofra™ technology shows promising results in collaboration with US biotech Tezcat Biosciences, advancing targeted drug delivery for cancer and inflammatory diseases.

Hot Chili Limited launches a A$14 million rights issue to fund key strategic initiatives, including advancing its La Verde copper-gold discovery and completing asset-level partnering processes within the Costa Fuego Project in Chile.

Unibail-Rodamco-Westfield N.V. reports a positive net income for the first half of 2025, driven by robust US shopping center performance and strategic investments. The company also advances its ESG commitments and plans to delist from the ASX by August.

Austal Limited has finalized a Strategic Shipbuilding Agreement with the Commonwealth of Australia, positioning its subsidiary as the nation’s key Tier 2 naval shipbuilder. This long-term pact sets the stage for significant defence vessel construction in Western Australia.

Everest Metals Corporation has secured regulatory approval to begin mining at its Mt Dimer Taipan Gold & Silver Project, targeting production commencement in late 2025. The project’s inferred resource and ongoing contract negotiations position EMC for a promising small-scale operation.

Key Petroleum Ltd has secured A$152,361 through a share placement aimed at supporting its merger preparations and corporate development initiatives.

Domain Holdings Australia has confirmed a one-week delay in the implementation of its proposed CoStar scheme of arrangement, now set for 27 August 2025.

Race Oncology’s Phase 1b/2 trial of RC110 bisantrene for relapsed or refractory acute myeloid leukemia has demonstrated a 40% response rate, exceeding expectations and offering new hope for difficult-to-treat patients.

Macarthur Minerals has successfully raised nearly $2 million through a rights issue, with Gold Valley Yilgarn Pty Ltd underwriting the shortfall and set to become a substantial shareholder pending approval.

WT Financial Group has reported a strong 21% increase in underlying net profit before tax for FY2025, driven by robust revenue growth and improved operational efficiency. The company also announced a new joint venture aimed at fueling future expansion.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

HeraMED Limited has raised $1.98 million through a discounted share placement to fund its digital maternity care platform's commercial growth across the US, Australia, and Europe.